Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Daire O'Shea"'
Autor:
Joerg Stelling, Michael Houghton, Thomas F. Mueller, Atul Humar, Luiz F. Lisboa, Lukas A. Widmer, Daire O'Shea, Adrian Egli, Deepali Kumar, Aliyah Baluch, Deanna M. Santer
Publikováno v:
The Journal of Infectious Diseases, 212 (1)
JOURNAL OF INFECTIOUS DISEASES
JOURNAL OF INFECTIOUS DISEASES
Background Influenza vaccine immunogenicity is suboptimal in immunocompromised patients. However, there are limited data on the interplay of T- and B- cell responses to vaccination with simultaneous immunosuppression. Methods We collected peripheral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::167fdf71a160cc0ca481b2c268359a8a
http://doc.rero.ch/record/303034/files/jiv015.pdf
http://doc.rero.ch/record/303034/files/jiv015.pdf
Publikováno v:
Current infectious disease reports. 16(9)
Infection prevention is a key component of care and an important determinant of clinical outcomes in a diverse population of immunocompromised hosts. Vaccination remains a fundamental preventative strategy, and clear guidelines exist for the vaccinat
Autor:
Khaled Barakat, Luiz F. Lisboa, Daire O'Shea, Atul Humar, Michael Houghton, Deanna M. Santer, D. Lorne Tyrrell, Rakesh Bhat, Adrian Egli, Karl P. Fischer, Aviad Levin, Brad S. Thomas, Michael A. Joyce, Deepali Kumar
Publikováno v:
The Journal of infectious diseases. 210(5)
BACKGROUND Feedback mechanisms between interferons α and λ (IFNs) may be affected by single nucleotide polymorphisms (SNP) in interleukin 28B (IL-28B; IFN-λ3) promoter region and may influence cytomegalovirus (CMV) replication. METHODS We associat
Publikováno v:
Emerging Microbes & Infections
Type-III interferons (IFN-λ, IFNL) are the most recently described family of IFNs. This family of innate cytokines are increasingly being ascribed pivotal roles in host-pathogen interactions. Herein, we will review the accumulating evidence detailin
Autor:
Daire O'Shea, G. Farrell, Clair M. Gardiner, Markus Peck-Radosavljevic, Thomas Reiberger, Colm Bergin, C Keane
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e66831 (2013)
PLoS ONE
PLoS ONE
Pegylated-IFN and ribavirin remains the current treatment for chronic HCV infection in patients co-infected with HIV-1, but this regimen has low efficacy rates, particularly for HCV genotype 1/4 infection, has severe side effects and is extremely cos
Autor:
Leticia E. Wilson, Luiz Augusto Ferreira Lisboa, Adrian Egli, Luis G. Hidalgo, Moacyr Silva, Daire O'Shea, Deepali Kumar, Aliyah Baluch, Atul Humar
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 11, p e43937 (2012)
PLoS ONE, Vol 7, Iss 11, p e43937 (2012)
BACKGROUND: CMV-specific T-cells are crucial to control CMV-replication post-transplant. Regulatory T-cells (T-regs) are associated with a tolerant immune state and may contribute to CMV-replication. However, T-cell subsets such as T-regs and IL-17 p